课题基金 / 基金详情

Pharmacological treatments for rheumatoid arthritis and inflammatory bowel disease: A network meta-analysis

Pharmacological treatments for rheumatoid arthritis and inflammatory bowel disease: A network meta-analysis
类风湿性关节炎和炎症性肠病的药物治疗：网络荟萃分析
批准号：
314237
负责人：
Wells George A
金额：
$12.77万
依托单位：
University of Ottawa Heart Institute
依托单位国家：
加拿大
项目类别：
Miscellaneous Programs
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-07-01 至 2015-07-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=314237&lang=en
关键词：
Bayesian Biologics Crohn'S Disease Efficacy Network Meta-Analysis Novel Agents Pharmacological Treatments Rheumatoid Arthritis Safety Ulcerative Colitis

项目摘要

项目成果

Wells George A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study is concerned with two major groups of disorders that are being treated with biologics, namely: rheumatoid arthritis (RA) which is a complex, progressive autoimmune disease; and Crohn's Disease (CD) and ulcerative colitis (UC) which are chronic,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Living systematic reviews of pharmacological treatments for Rheumatoid Arthritis
  • 批准号：
    445559
  • 项目类别：
    Operating Grants
  • 资助金额：
    $28.14万
  • 财政年份：
    2021
  • 负责人：
    Wells George A
  • 依托单位：
    University of Ottawa Heart Institute
Active Surveillance for Safety and Effectiveness of Health Products for COVID-19
New oral anticoagulants for the treatment and prevention of venous thromboembolism: A systematic review and network meta-analysis
  • 批准号：
    314236
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $8.73万
  • 财政年份：
    2014
  • 负责人：
    Wells George A
  • 依托单位：
    University of Ottawa Heart Institute
A Network Meta-Analysis of the Cardio-Cerebrovascular Risk Associated with the Anti-Parkinsonian Combination of levodopa/carbidopa/entacapone
  • 批准号：
    259884
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $7.02万
  • 财政年份：
    2012
  • 负责人：
    Wells George A
  • 依托单位：
    University of Ottawa Heart Institute
海外基金